The New York Times reports that recently released court documents suggest that drugmaker Wyeth was behind more than two dozen ghostwritten articles published in medical journals from 1998 to 2005 that significantly advanced the use of hormone replacement treatments in women. The articles, commission by drug maker Wyeth, touted the benefits of the hormone drugs Premarin and Prempro while downplaying potential risks. Later studies determined that some hormone therapies increased the risk of a variety of health problems among menopausal women. Article by Natasha Singer, The New York Times 08/04/2009